I, a protein platform for reprogramming immune responses. A better understanding of its structure may help optimize designs for the platform, which can be used to develop cancer treatments by either ...

Patients found to have positive lymph nodes after robotic radical cystectomy for muscle-invasive bladder cancer may benefit from treatment de-escalation if they have undetectable circulating tumor ...

Breast cancer cells exhibit organotropism during metastasis, showing preferential homing to certain organs such as bone, lung, liver, and brain. One potential explanation for this organotropic ...

On Monday, the company said it was stopping two trials of vibostolimab with Keytruda to treat non-small cell lung cancer after an analysis showed it was unlikely to succeed, while it also decided ...

What if cancer cells became their own enemies? A team from Stanford seems to have found a way to achieve this goal. In our bodies, billions of cells are destroyed daily thanks to a process called ...

Researchers have identified a form of vitamin B6 bound to MR1 as a means of engaging tumor-reactive immune cells. Effective immunity hinges on the ability to sense infection and cellular ...

This Research Topic aims to elaborate on the heterogeneity of circulating tumor cells (CTCs) and their role in cancer risk, progression, and response to therapies. We also intend to shed light on ...

Immunotherapy works by harnessing the body's own immune system to eliminate cancer cells, either by broadly enhancing immune activity or by targeting specific pathways to recognize, attack ...

They suggested that the nano-gripper could be used to detect and capture other viruses, such as HIV and influenza, and possibly even target cancer cells.